Royal Bank of Canada
THRD

Royal Bank of Canada’s Third Harmonic Bio THRD Stock Holding History

Royal Bank of Canada’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,699
Closed -$85K – 7525
2025
Q2 		$85K Buy
15,699
+12,774
+437% +$63.7K ﹤0.01% 5697
2025
Q1 		$10K Sell
2,925
-3,080
-51% -$14.9K ﹤0.01% 6165
2024
Q4 		$62K Buy
6,005
+2,843
+90% +$35.4K ﹤0.01% 5587
2024
Q3 		$43K Buy
3,162
+1,187
+60% +$14.7K ﹤0.01% 5777
2024
Q2 		$25K Buy
1,975
+1,528
+342% +$18.9K ﹤0.01% 5971
2024
Q1 		$4K Sell
447
-5,624
-93% -$54.7K ﹤0.01% 6531
2023
Q4 		$67K Buy
6,071
+2,444
+67% +$19.4K ﹤0.01% 5852
2023
Q3 		$23K Buy
3,627
+1,501
+71% +$9.17K ﹤0.01% 6134
2023
Q2 		$10K Buy
2,126
+1,420
+201% +$6.76K ﹤0.01% 6487
2023
Q1 		$3K Sell
706
-1,315
-65% -$5.58K ﹤0.01% 6711
2022
Q4 		$9K Sell
2,021
-3,536
-64% -$59.2K ﹤0.01% 6584
2022
Q3 		$105K Buy
+5,557
New +$100K ﹤0.01% 5279

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada's THRD Position: Q3 2025 in Review

Royal Bank of Canada sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 15,699 shares — an estimated $85K sold.

Royal Bank of Canada first reported a position in THRD in Q3 2022 and held it in 12 quarters. The position peaked at $105K in Q3 2022. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Royal Bank of Canada reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 15,699 Third Harmonic Bio shares in Q3 2025, an estimated $85K.
  • Royal Bank of Canada first reported a position in Third Harmonic Bio in Q3 2022 and held it in 12 quarters.
  • Royal Bank of Canada's Third Harmonic Bio position peaked at $105K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.